How a target safety assessment supports the drug development process

<p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">In the latest sponsored DDW Sitting Down With podcast Professor</span> <span lang="EN-US" xml:lang="EN-US">Ruth Roberts, Co-Founder ApconiX and Claire Sadler, Project Toxicologist, </span><span lang="EN-US" xml:lang= "EN-US">discuss</span> <span lang="EN-US" xml:lang="EN-US">the benefits of carrying out a target safety assessment (TSA) during drug discovery and development whenever a biological target is going to be <a>modulated.</a></span></p> <p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">The speakers outline how</span> <span lang="EN-US" xml:lang= "EN-US">TSAs can be used throughout the drug discovery and development pathway and offer examples of best practice and potential next steps.</span></p> <p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">Listen now. </span></p>